Karuna KarXT FDA approval

Karuna KarXT FDA approval, KarXT schizophrenia drug, Karuna biotech company, KarXT muscarinic receptors, KarXT novel mechanism of action, KarXT phase 3 trial results, KarXT safety and efficacy,

Karuna submits KarXT, a novel schizophrenia drug, to FDA for approval

Anika Sharma

Karuna Pharmaceuticals has taken a significant step towards gaining approval for its schizophrenia drug, KarXT, as it formally submitted its ...